European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.81% to 1,363.17 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and biopharmaceutical company argenx (ARGX), which rose 2.6% and 1.5% respectively. They were followed by software firm SAP (SAP) and energy company Equinor (EQNR), which were up 1.4% and 1.3% respectively.
The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies (DBVT) and Genfit (GNFT), which fell 5.2% and 2.8% respectively. They were followed by biopharmaceutical company Grifol (GRFS) and furniture maker Natuzzi (NTZ), which dropped 2.2% and 0.8% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical companies NuCana (NCNA) and Biodexa Pharmaceuticals (BDRX), which increased 4.3% and 3% respectively. They were followed by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), which rose 2.4% and 2.3% respectively.
The decliners from the UK and Ireland were led by biotech company Trinity Biotech (TRIB) and biopharmaceutical company Amarin (AMRN), which lost 6.4% and 3.9% respectively. They were followed by alcoholic beverage company Diageo (DEO) and pharmaceutical company Silence Therapeutics (SLN), which were down 1.8% and 1.5% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。